Karleigh McClain of Hendersonville, Tennessee, signed up for a membership with a telehealth company in January so that she could start taking a GLP-1 drug for weight loss
Similarly, oculomotor binocular dysfunction (HR 0.31, 95% CI: 0.160.60, p = 2 10 4 ), visual issues and blindness (HR 0.44, 95% CI: 0.260.76, p = 0.003), dry eye disease (HR 0.33, 95% CI: 0.150.71, p = 0.003), ametropic accommodative dysfunction (HR 0.31, 95% CI: 0.160.62, p = 2.3 10 4 ), and visual disturbances (HR 0.46, 95% CI: 0.260.83, p = 0.008) all showed statistically significant associations favoring Tirzepatide
Universal response: 100% of participants on 812 mg achieved at least 5% weight reduction [4]
Its all about understanding the complete picture
But among those patients who are taking the drugs, we are seeing improvements in health
In the same study, it was found that GLP-1RA can affect progenitor endothelial cells (EPCs)